Victory Square Provides Update on Hydreight and Healthcare Investments Following FDA Advisory Committee Recommendations on Peptide-Related Bulk Drug Substances

Go back to Victory Square Provides Update on Hydreight and Healthcare Investments Following FDA Advisory Committee Recommendations on Peptide-Related Bulk Drug Substances
(AMEX: VSQTF) Delayed: 0.44 +0.02 (4.76%)
Previous Close $0.42    52 Week High
Open $0.40    52 Week Low
Day High $0.45    P/E N/A 
Day Low $0.40    EPS
Volume 125,948       

(NYSE: VST) Delayed: 149.30 +5.08 (3.52%)
Previous Close $144.22    52 Week High
Open $143.87    52 Week Low
Day High $149.45    P/E N/A 
Day Low $143.16    EPS
Volume 4,608,342